Tumor Model and Biospecimen Repository Core
肿瘤模型和生物样本库核心
基本信息
- 批准号:10518176
- 负责人:
- 金额:$ 6.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-20 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:Animal ModelBiological MarkersBiological Specimen BanksBloodCancer cell lineCell LineCell MaintenanceClinicalCollectionCytologyDatabase Management SystemsDatabasesDevelopmentDiagnosisDrug or chemical Tissue DistributionEnsureEvaluationFine needle aspiration biopsyFosteringGuidelinesHarvestHead and Neck CancerHead and Neck Squamous Cell CarcinomaHealth Insurance Portability and Accountability ActHuman ResourcesImmunohistochemistryIndividualLaboratoriesLeadLeadershipLinkMalignant - descriptorMedicineModelingMusNucleic AcidsPathologicPathologyPatientsPreparationProcessResearchResearch PersonnelResistanceResourcesSamplingSecureServicesSpecimenTechniquesTissue BanksTissue MicroarrayTissue SampleTissuesUnited States National Institutes of HealthUniversity of Texas M D Anderson Cancer CenterWestern Blottingbasecollegecytokineimmunosuppressedinnovationpatient derived xenograft modelperipheral bloodproduct developmentprogramsrepositorytumor
项目摘要
Tumor Model and Biospecimen Repository Core (Core C) SUMMARY
Tumor Model and Biospecimen Repository Core (Core C) led by Dr. Adel K. El-Naggar (Core Leader) and Dr.
Jeffrey Myers (Core Co-Leader), will provide H-CARR investigators with a centralized facility that ensures the
systematic collection, processing, storage, and distribution of peripheral blood, surrogate and specialized
specimens, and samples of head and neck squamous cell carcinoma (HNSCC) from patients diagnosed, treated,
and followed at The University of Texas MD Anderson Cancer Center (MD Anderson) at Baylor College of
Medicine (BCM). Core C also provides expert preparation and distribution of high-quality samples and ancillary
techniques to optimize utilization of patients’ materials by H-CARR investigators. Procurement and distribution
of the samples to individual investigators will follow the guidelines established by the H-CARR Center Executive
Leadership Committee and in compliance with HIPAA. Core C leadership will provide detailed pathologic
evaluation of all tumor samples to investigators through the secure pathology database system linked to the H-
CARR, database, and server. Core C will perform specialized services, including tissue microarray (TMA)
construction, qualitative and quantitative biomarker analyses both in tissue [e.g., immunohistochemistry (IHC),
Western blotting] and non-tissue (e.g., blood-based cytokine profiles) specimens, nucleic acid extractions, and
development and maintenance of cell lines. Core C will also provide well-characterized, genomically
authenticated head and neck cancer cell lines, well-characterized patient-derived xenograft (PDX) models, and
heterotopic and orthotopic animal models in immunosuppressed or syngeneic mice and autochthonous tumor
models of HNSCC to investigators. The leadership and personnel of Core C and its centralized organization will
ensure the highest quality tissue samples and related analyses to all H-CARR investigators and to collaborating
researchers participating in other NIH/NCI-sponsored programs.
肿瘤模型和生物样本库核心(核心C)总结
肿瘤模型和生物样本库核心(核心C)由阿德尔K博士领导。El-Naggar(核心负责人)和Dr.
Jeffrey Myers(核心联合负责人)将为H-CARR研究人员提供一个集中的设施,以确保
系统收集、处理、储存和分配外周血、替代血和专业血
样本和头颈部鳞状细胞癌(HNSCC)的样本,
并在贝勒大学德克萨斯大学医学博士安德森癌症中心(MD安德森)进行了随访。
医学(英语:Medicine)核心C还提供专家准备和高质量的样品和辅助分配
H-CARR研究人员优化患者材料利用的技术。采购和分配
将样本分发给各个研究者将遵循H-CARR中心执行官制定的指南
领导委员会和遵守HIPAA。核心C领导层将提供详细的病理检查结果,
通过与H-2000网络连接的安全病理学数据库系统,对研究者的所有肿瘤样本进行评估。
卡尔、数据库和服务器。核心C将执行专门的服务,包括组织微阵列(TMA)
构建、组织中的定性和定量生物标志物分析[例如,免疫组织化学(IHC),
Western印迹]和非组织(例如,基于血液的细胞因子谱)标本、核酸提取物,以及
细胞系的开发和维持。核心C还将提供良好表征的、基因组学上的
经验证的头颈癌细胞系,充分表征的患者来源的异种移植物(PDX)模型,以及
免疫抑制或同源小鼠异位和原位动物模型及原位肿瘤
HNSCC的模型。核心C的领导层和人员及其集中组织将
确保向所有H-CARR研究者提供最高质量的组织样本和相关分析,
参与其他NIH/NCI赞助项目的研究人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ADEL K. EL-NAGGAR其他文献
ADEL K. EL-NAGGAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ADEL K. EL-NAGGAR', 18)}}的其他基金
Molecular and Epidemiologic Characterization of Salivary Gland Carcinomas
唾液腺癌的分子和流行病学特征
- 批准号:
8081912 - 财政年份:2009
- 资助金额:
$ 6.94万 - 项目类别:
Molecular and Epidemiologic Characterization of Salivary Gland Carcinomas
唾液腺癌的分子和流行病学特征
- 批准号:
7679833 - 财政年份:2009
- 资助金额:
$ 6.94万 - 项目类别:
Molecular and Epidemiologic Characterization of Salivary Gland Carcinomas
唾液腺癌的分子和流行病学特征
- 批准号:
8082621 - 财政年份:2009
- 资助金额:
$ 6.94万 - 项目类别:
Molecular and Epidemiologic Characterization of Salivary Gland Carcinomas
唾液腺癌的分子和流行病学特征
- 批准号:
8514402 - 财政年份:2009
- 资助金额:
$ 6.94万 - 项目类别:
Molecular and Epidemiologic Characterization of Salivary Gland Carcinomas
唾液腺癌的分子和流行病学特征
- 批准号:
8535979 - 财政年份:2009
- 资助金额:
$ 6.94万 - 项目类别:
Molecular and Epidemiologic Characterization of Salivary Gland Carcinomas
唾液腺癌的分子和流行病学特征
- 批准号:
8288813 - 财政年份:2009
- 资助金额:
$ 6.94万 - 项目类别:
Molecular and Epidemiologic Characterization of Salivary Gland Carcinomas
唾液腺癌的分子和流行病学特征
- 批准号:
7935295 - 财政年份:2009
- 资助金额:
$ 6.94万 - 项目类别:
相似海外基金
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10490338 - 财政年份:2021
- 资助金额:
$ 6.94万 - 项目类别:
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10353104 - 财政年份:2021
- 资助金额:
$ 6.94万 - 项目类别:
Investigating pollution dynamics of swimming pool waters by means of chemical and biological markers
利用化学和生物标记物研究游泳池水体的污染动态
- 批准号:
21K04320 - 财政年份:2021
- 资助金额:
$ 6.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10688286 - 财政年份:2021
- 资助金额:
$ 6.94万 - 项目类别:
Novel biological markers for immunotherapy and comprehensive genetic analysis in thymic carcinoma
用于胸腺癌免疫治疗和综合遗传分析的新型生物标志物
- 批准号:
20K17755 - 财政年份:2020
- 资助金额:
$ 6.94万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10578649 - 财政年份:2019
- 资助金额:
$ 6.94万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10295141 - 财政年份:2019
- 资助金额:
$ 6.94万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10041708 - 财政年份:2019
- 资助金额:
$ 6.94万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
9776149 - 财政年份:2019
- 资助金额:
$ 6.94万 - 项目类别:
Combining biological and non-biological markers to develop a model predictive of treatment response for individuals with depression
结合生物和非生物标志物来开发预测抑郁症患者治疗反应的模型
- 批准号:
2063934 - 财政年份:2018
- 资助金额:
$ 6.94万 - 项目类别:
Studentship